- Home
- RNR vs PEN Comparison
RNR vs PEN Comparison
Compare RNR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNR
- PEN
- Stock Information
- Founded
- RNR 1993
- PEN 2004
- Country
- RNR Bermuda
- PEN United States
- Employees
- RNR N/A
- PEN N/A
- Industry
- RNR Property-Casualty Insurers
- PEN Medical/Dental Instruments
- Sector
- RNR Finance
- PEN Health Care
- Exchange
- RNR Nasdaq
- PEN Nasdaq
- Market Cap
- RNR 11.5B
- PEN 9.9B
- IPO Year
- RNR 1995
- PEN 2015
- Fundamental
- Price
- RNR $267.66
- PEN $246.92
- Analyst Decision
- RNR Hold
- PEN Strong Buy
- Analyst Count
- RNR 13
- PEN 16
- Target Price
- RNR $286.09
- PEN $301.93
- AVG Volume (30 Days)
- RNR 440.4K
- PEN 406.5K
- Earning Date
- RNR 10-28-2025
- PEN 10-29-2025
- Dividend Yield
- RNR 0.60%
- PEN N/A
- EPS Growth
- RNR N/A
- PEN 916.05
- EPS
- RNR 39.14
- PEN 3.74
- Revenue
- RNR $12,974,536,000.00
- PEN $1,280,152,000.00
- Revenue This Year
- RNR N/A
- PEN $15.52
- Revenue Next Year
- RNR $3.65
- PEN $14.20
- P/E Ratio
- RNR $6.84
- PEN $66.61
- Revenue Growth
- RNR 22.84
- PEN 12.92
- 52 Week Low
- RNR $219.00
- PEN $190.08
- 52 Week High
- RNR $300.00
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- RNR 74.20
- PEN 39.91
- Support Level
- RNR $255.00
- PEN $242.41
- Resistance Level
- RNR $259.17
- PEN $260.89
- Average True Range (ATR)
- RNR 4.91
- PEN 7.31
- MACD
- RNR 2.15
- PEN -1.10
- Stochastic Oscillator
- RNR 83.78
- PEN 19.70
About RNR RenaissanceRe Holdings Ltd.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.